February 6, 2014
Fujifilm Pharma will exclusively distribute in Japan Sosei’s experimental antifungal agent SO-1105 (miconazole), which is in PIII development for oropharyngeal candidiasis. Under a deal cut between the two companies, Sosei will be responsible for the drug’s regulatory filing, production, and...read more